SEC Company Response from Ernexa Therapeutics Inc. (ERNA, ERNAW) (CIK 0000748592) (ERNA) — Feb 6, 2008
Ernexa Therapeutics Inc. (ERNA, ERNAW) (CIK 0000748592)
Date: Feb. 6, 2008 · CIK: 0000748592 · Accession: 0001193125-08-021654
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-11460
Referenced dates: January 28, 2008
Letter
Via Edgarlink Securities and Exchange Commission Division of Corporation Finance Attention: Mr. Larry Spirgel, Assistant Director Re: NTN Buzztime, Inc. Form 10-K for Fiscal Year Ended December 31, 2006, Filed March 16, 2007 Form 10-Q for Fiscal Quarter Ended June 30, 2007 File No. 001-11460
Dear Mr. Spirgel, Mr. Moffatt and Ms. Kessman:
We have received your comment letter dated January 28, 2008 relating to the NTN Buzztime, Inc. filings described above and we are in the process of preparing a response. As a follow-up to our telephone conversation, we expect to submit a response to you on or before February 18, 2008.
Very truly yours,
/s/ Kendra Berger
Show Raw Text
CORRESP 1 filename1.htm Correspondence February 6, 2008 Via Edgarlink Securities and Exchange Commission Division of Corporation Finance Mail Stop 3720 Washington, D.C. 20549 Attention: Mr. Larry Spirgel, Assistant Director Mr. Kyle Moffatt, Accounting Branch Chief Ms. Inessa Kessman, Senior Staff Accountant Re: NTN Buzztime, Inc. Form 10-K for Fiscal Year Ended December 31, 2006, Filed March 16, 2007 Form 10-Q for Fiscal Quarter Ended June 30, 2007 File No. 001-11460 Dear Mr. Spirgel, Mr. Moffatt and Ms. Kessman: We have received your comment letter dated January 28, 2008 relating to the NTN Buzztime, Inc. filings described above and we are in the process of preparing a response. As a follow-up to our telephone conversation, we expect to submit a response to you on or before February 18, 2008. Very truly yours, /s/ Kendra Berger Kendra Berger, Chief Financial Officer cc: Kirt Shuldberg, Heller Ehrman LLP